Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ross Maltz"'
Autor:
Emily B. Hill, Li Chen, Michael T. Bailey, Amrik Singh Khalsa, Ross Maltz, Kelly Kelleher, Colleen K. Spees, Jiangjiang Zhu, Brett R. Loman
Publikováno v:
Gut Microbes, Vol 14, Iss 1 (2022)
Low-resource individuals are at increased risk of obesity and cardiovascular disease (CVD), partially attributable to poor dietary patterns and dysfunctional microbiota. Dietary patterns in childhood play critical roles in physiological development a
Externí odkaz:
https://doaj.org/article/e3ee623a38b54c62a2466d5f5357f9b0
Autor:
Madeline McClinchie, Alyshah Lakhani, Mahmoud Abdel-Rasoul, Megan McNicol, Ala Shaikhkhalil, Brendan Boyle, Ross Maltz
Publikováno v:
Gastroenterology. 164:S78
BACKGROUND Biosimilars are biologic products similar in safety and efficacy to the originator product. Tumor necrosis factor-alpha inhibitors (anti-TNFs) are used in the treatment of inflammatory bowel diseases (IBD). There are limited studies evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6083ba50a7a4356250874904b3254930
https://doi.org/10.1053/j.gastro.2023.03.146
https://doi.org/10.1053/j.gastro.2023.03.146
Autor:
Megan McNicol, Mahmoud Abdel-Rasoul, Grant Morris, Brendan Boyle, Jennifer Dotson, Hilary Michel, Ross Maltz
Publikováno v:
Inflammatory Bowel Diseases. 29:S62-S62
BACKGROUND Studies in adults with inflammatory bowel disease (IBD) have demonstrated that a one-time switch from the originator to a biosimilar has not resulted in loss of response, increased side effects, or antibody development. Data describing non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f3f61368ae88a80ee13afb073a36b7
https://doi.org/10.1093/ibd/izac247.117
https://doi.org/10.1093/ibd/izac247.117
Autor:
Kathryn Hawa, Ross Maltz, Amy Donegan, Vinay Prasad, Jennifer L. Dotson, Brendan Boyle, Hilary K. Michel
Publikováno v:
JPGN Reports. 3:e255
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::169b486f75a6193354d7dc9bf6b28926
https://doi.org/10.1097/pg9.0000000000000255
https://doi.org/10.1097/pg9.0000000000000255
Autor:
Ross Maltz, Alessandra C. Gasior
Publikováno v:
Pediatric Colorectal and Pelvic Reconstructive Surgery ISBN: 9780429027789
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::261fce2254ce2f2a97716c0bb444e0fc
https://doi.org/10.1201/9780429027789-23
https://doi.org/10.1201/9780429027789-23
Publikováno v:
Inflammatory Bowel Diseases. 28:S1-S1
INTRODUCTION Pediatric inflammatory bowel disease (IBD) is commonly treated with infliximab in a hospital setting or clinic where infusions are safely and effectively administered. In recent years, utilization of home infusions (HI) has increased due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ad78decfaad9c0e763bdf9be36163c1
https://doi.org/10.1093/ibd/izac015.000
https://doi.org/10.1093/ibd/izac015.000
Publikováno v:
Current opinion in pediatrics. 26(5)
Purpose of review To review the various imaging modalities in the evaluation of pediatric inflammatory bowel disease (IBD) to determine disease location, clinical phenotype and the severity of disease in order to optimize treatment. Recent findings A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b002618c8140958c8eee512b95902b
https://pubmed.ncbi.nlm.nih.gov/25029227
https://pubmed.ncbi.nlm.nih.gov/25029227